Observational studyJournal of gastroenterology and hepatology2026
Comparing the Effect of Changes in Alcohol Intake on Liver Fibrosis Risk Scores Among Patients With Two Distinct Types of Steatotic Liver Disease.
Observational study in Journal of gastroenterology and hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
BACKGROUND AND
aimFibrosis determines the prognosis of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction and alcohol-associated liver disease (MetALD). However, how changes in alcohol consumption affect fibrosis progression in MASLD and MetALD remains unclear. We aimed to evaluate the longitudinal association between changes in alcohol intake and fibrosis risk scores (FRS) in patients with MASLD and MetALD.
methodsIn this retrospective observational cohort study, 2198 patients with MASLD and 644 with MetALD underwent three health check-ups, each conducted at least 1 year apart. Associations between changes in alcohol intake and the worsening FRS were assessed using Cox proportional hazards models.
resultsFRS were higher in patients with MetALD than in those with MASLD. Among men with MASLD, changes in alcohol intake were not associated with worsening FRS; however, women with MASLD who increased alcohol consumption experienced worsening FRS. In patients with MetALD, including men with MetALD consuming 280-419.9 g/week of alcohol, reducing alcohol intake was associated with a lower risk of worsening FRS than that in individuals who maintained the same consumption level.
conclusionsThe influence of changes in alcohol intake on FRS varied by sex and disease type. Although fibrosis risk scores were more advanced in patients with MetALD than in those with MASLD, reducing alcohol consumption was associated with a lower risk of further worsening FRS in patients with MetALD. These findings highlight the importance of considering both sex and changes in alcohol consumption when evaluating fibrosis risk in patients with MASLD or MetALD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.